Fischer Medical Ventures has partnered with the City of Jember, Indonesia, to deploy portable, AI-powered X-ray systems aimed at eradicating tuberculosis by 2026. This initiative marks the company’s strategic healthcare entry into Indonesia, combining innovation, access, and impact to transform public health outcomes. The company is estimating the program value to be over $10 million with an implementation plan over 2 years in multiple phases.
For the Company, this initiative is not just exercising its corporate social responsibility, it is a strategic move into a 280 million population country with huge opportunities from its public health plans, especially to fight TB, an infectious disease that can lead to death if not treated promptly. Indonesia continues to battle one of the highest burdens of TB in the world, alongside India and China. A key challenge remains: limited access to early detection and treatment
Fischer Medical Ventures is engaged in the trading of certain grades of Laboratory Chemicals.
| Company Name | CMP |
|---|---|
| Redington | 234.90 |
| Adani Enterprises | 2218.35 |
| Amrapali Industries | 17.53 |
| Rashi Peripheral | 455.25 |
| PDS | 301.45 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: